Tvardi Therapeutics, Inc. short interest in 2024
In 2024, Tvardi Therapeutics, Inc.'s disclosed short interest ran from 4.38% of shares outstanding on 12 Jan 2024 to 0.60% on 13 Dec 2024, a change of -3.78 percentage points. The year's high was 4.78% on 30 Apr 2024 and its low 0.60% on 13 Dec 2024, averaging 3.15% across 22 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.55 days on 15 May 2024. Full history: Tvardi Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 4.38% (12 Jan 2024)
- End of year
- 0.60% (13 Dec 2024)
- Change
- -3.78 pp
- High
- 4.78% (30 Apr 2024)
- Low
- 0.60% (13 Dec 2024)
- Average
- 3.15%
- Highest days to cover
- 9.55 (15 May 2024)
- SEC filings marked
- 6
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 4.38% | 3.40 | |
| 31 Jan 2024 | 4.62% | 4.19 | |
| 15 Feb 2024 | 4.10% | 4.82 | |
| 29 Feb 2024 | 4.38% | 1.92 | |
| 15 Mar 2024 | 4.54% | 2.66 | results (8-K), 10-K filed |
| 28 Mar 2024 | 4.71% | 5.87 | |
| 15 Apr 2024 | 4.77% | 7.26 | |
| 30 Apr 2024 | 4.78% | 8.45 | |
| 15 May 2024 | 4.47% | 9.55 | 10-Q filed, results (8-K) |
| 31 May 2024 | 4.21% | 6.58 | |
| 14 Jun 2024 | 4.16% | 2.83 | |
| 28 Jun 2024 | 3.53% | 1.00 | |
| 31 Jul 2024 | 1.54% | 1.54 | |
| 15 Aug 2024 | 2.66% | 5.44 | 10-Q filed |
| 30 Aug 2024 | 2.03% | 3.38 | |
| 13 Sep 2024 | 2.20% | 2.77 | |
| 30 Sep 2024 | 1.52% | 2.28 | |
| 15 Oct 2024 | 1.11% | 2.42 | |
| 31 Oct 2024 | 1.72% | 1.57 | |
| 15 Nov 2024 | 2.30% | 1.37 | 10-Q filed |
| 29 Nov 2024 | 1.05% | 1.19 | |
| 13 Dec 2024 | 0.60% | 1.00 |
See also: Tvardi Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.